Literature DB >> 9486420

Cytokine release and its modulation by dexamethasone in whole blood following exercise.

H H Smits1, K Grünberg, R H Derijk, P J Sterk, P S Hiemstra.   

Abstract

Glucocorticoids (GC) play an important role in the treatment of inflammatory diseases like asthma. However, in selected patients a relative resistance to GC has been reported. Recently, it has been suggested that GC sensitivity of peripheral blood leucocytes may be regulated in a dynamic fashion during exercise, in association with activation of the hypothalamic-pituitary-adrenal (HPA) axis. The aim of the present study was to explore changes in the GC sensitivity of cytokine production by leucocytes following strenuous exercise by well trained oarsmen. These changes were studied using lipopolysaccharide (LPS)-induced and anti-CD2/anti-CD28 MoAb-stimulated cytokine release in whole blood and its modulation by dexamethasone. Following exercise, significant decreases in LPS-induced release of IL-6, tumour necrosis factor-alpha (TNF-alpha) and IL-10 and anti-CD2/anti-CD28 MoAb-stimulated secretion of interferon-gamma (IFN-gamma) were observed. In addition, the inhibitory effect of dexamethasone on both IL-6 and TNF-alpha secretion was significantly reduced following exercise, whereas that on IL-10 and IFN-gamma release was not affected. These exercise-induced changes were accompanied by activation of the HPA axis, as indicated by an increase in circulating adrenocorticotropic hormone (ACTH) levels immediately following exercise. The results from the present study suggest that GC sensitivity of whole blood cytokine release can be regulated in a dynamic fashion and that this can be assessed using an ex vivo stimulation assay. Moreover, since dexamethasone responsiveness of anti-CD2/anti-CD28 MoAb-induced IFN-gamma secretion in whole blood is not affected by exercise, it may suggest that exercise differentially affects monocytes and lymphocytes. The dynamic regulation of steroid responsiveness of leucocytes, as observed in the present study, could have important consequences for the effectiveness of GC treatment in inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9486420      PMCID: PMC1904898          DOI: 10.1046/j.1365-2249.1998.00482.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  34 in total

Review 1.  Mechanisms of action of glucocorticoids in asthma.

Authors:  P J Barnes
Journal:  Am J Respir Crit Care Med       Date:  1996-08       Impact factor: 21.405

Review 2.  Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids.

Authors:  C M Bamberger; H M Schulte; G P Chrousos
Journal:  Endocr Rev       Date:  1996-06       Impact factor: 19.871

3.  Mechanism of glucocorticoid receptor down-regulation by glucocorticoids.

Authors:  S Rosewicz; A R McDonald; B A Maddux; I D Goldfine; R L Miesfeld; C D Logsdon
Journal:  J Biol Chem       Date:  1988-02-25       Impact factor: 5.157

4.  Exercise and circadian rhythm-induced variations in plasma cortisol differentially regulate interleukin-1 beta (IL-1 beta), IL-6, and tumor necrosis factor-alpha (TNF alpha) production in humans: high sensitivity of TNF alpha and resistance of IL-6.

Authors:  R DeRijk; D Michelson; B Karp; J Petrides; E Galliven; P Deuster; G Paciotti; P W Gold; E M Sternberg
Journal:  J Clin Endocrinol Metab       Date:  1997-07       Impact factor: 5.958

Review 5.  Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies.

Authors:  R Brattsand; M Linden
Journal:  Aliment Pharmacol Ther       Date:  1996       Impact factor: 8.171

Review 6.  Glucocorticosteroid inhibition of cytokine production: relevance to antiallergic actions.

Authors:  L M Schwiebert; L A Beck; C Stellato; C A Bickel; B S Bochner; R P Schleimer; L A Schwiebert
Journal:  J Allergy Clin Immunol       Date:  1996-01       Impact factor: 10.793

7.  Interleukin-1, -6 and tumor necrosis factor-alpha release is down-regulated in whole blood from septic patients.

Authors:  J P Kremer; D Jarrar; U Steckholzer; W Ertel
Journal:  Acta Haematol       Date:  1996       Impact factor: 2.195

8.  Effects of glucocorticoids on lymphocyte activation in patients with steroid-sensitive and steroid-resistant asthma.

Authors:  J D Spahn; L P Landwehr; S Nimmagadda; W Surs; D Y Leung; S J Szefler
Journal:  J Allergy Clin Immunol       Date:  1996-12       Impact factor: 10.793

9.  In vitro and in vivo modulation of alpha- and beta-glucocorticoid-receptor mRNA in human bronchial epithelium.

Authors:  S H Korn; E F Wouters; G Wesseling; J W Arends; F B Thunnissen
Journal:  Am J Respir Crit Care Med       Date:  1997-03       Impact factor: 21.405

10.  Effect of xanthine derivates and dexamethasone on Streptococcus pneumoniae-stimulated production of tumor necrosis factor alpha, interleukin-1 beta (IL-1 beta), and IL-10 by human leukocytes.

Authors:  A M van Furth; E M Seijmonsbergen; J A Langermans; P H van der Meide; R van Furth
Journal:  Clin Diagn Lab Immunol       Date:  1995-11
View more
  13 in total

1.  Seven days' around the clock exhaustive physical exertion combined with energy depletion and sleep deprivation primes circulating leukocytes.

Authors:  Yngvar Gundersen; Per Kristian Opstad; Trine Reistad; Ingjerd Thrane; Per Vaagenes
Journal:  Eur J Appl Physiol       Date:  2006-02-28       Impact factor: 3.078

2.  Acute high-intensity interval exercise reduces human monocyte Toll-like receptor 2 expression in type 2 diabetes.

Authors:  Cody Durrer; Monique Francois; Helena Neudorf; Jonathan P Little
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-01-25       Impact factor: 3.619

3.  Optimization of cell-based assays to quantify the anti-inflammatory/allergic potential of test substances in 96-well format.

Authors:  C V Chandrasekaran; R Edwin Jothie; Preeti Kapoor; Anumita Gupta; Amit Agarwal
Journal:  Inflammopharmacology       Date:  2010-10-31       Impact factor: 4.473

4.  Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD.

Authors:  Diana C Grootendorst; Stefanie A Gauw; Renate M Verhoosel; Peter J Sterk; Jeannette J Hospers; Dirk Bredenbröker; Thomas D Bethke; Pieter S Hiemstra; Klaus F Rabe
Journal:  Thorax       Date:  2007-06-15       Impact factor: 9.139

5.  Intense physical exercise increases systemic 11beta-hydroxysteroid dehydrogenase type 1 activity in healthy adult subjects.

Authors:  Andrea Dovio; Eliana Roveda; Chiara Sciolla; Angela Montaruli; Andrea Raffaelli; Alessandro Saba; Giovanna Calogiuri; Silvia De Francia; Paolo Borrione; Piero Salvadori; Franca Carandente; Alberto Angeli
Journal:  Eur J Appl Physiol       Date:  2009-11-10       Impact factor: 3.078

6.  Effects of physical training on the immune system in diabetic rats.

Authors:  Daniel Maciel Crespilho; José Alexandre Curiacos de Almeida Leme; Maria Alice Rostom de Mello; Eliete Luciano
Journal:  Int J Diabetes Dev Ctries       Date:  2010-01

7.  Cytokine signatures of human whole blood for monitoring immunosuppression.

Authors:  Yi He; Yuwei Luo; Xiaobin Lao; Liping Tan; Erwei Sun
Journal:  Cent Eur J Immunol       Date:  2014-10-14       Impact factor: 2.085

8.  Biomarker Profiles in Asthma With High vs Low Airway Reversibility and Poor Disease Control.

Authors:  William W Busse; Stephen T Holgate; Sally W Wenzel; Paul Klekotka; Yun Chon; JingYuan Feng; Edward P Ingenito; Ajay Nirula
Journal:  Chest       Date:  2015-12       Impact factor: 9.410

9.  Influence of Hydration Status on Changes in Plasma Cortisol, Leukocytes, and Antigen-Stimulated Cytokine Production by Whole Blood Culture following Prolonged Exercise.

Authors:  Ida S Svendsen; Sophie C Killer; Michael Gleeson
Journal:  ISRN Nutr       Date:  2014-03-12

10.  Dexamethasone Protects Against Tourniquet-Induced Acute Ischemia-Reperfusion Injury in Mouse Hindlimb.

Authors:  Ryan M Corrick; Huiyin Tu; Dongze Zhang; Aaron N Barksdale; Robert L Muelleman; Michael C Wadman; Yu-Long Li
Journal:  Front Physiol       Date:  2018-03-20       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.